Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has been assigned a consensus rating of “Hold” from the four analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $4.00.
BIOX has been the subject of a number of recent research reports. Wall Street Zen downgraded shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. Weiss Ratings raised shares of Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a report on Tuesday, May 26th.
Read Our Latest Stock Report on Bioceres Crop Solutions
Bioceres Crop Solutions Stock Performance
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.11). The business had revenue of $39.40 million during the quarter, compared to the consensus estimate of $54.50 million. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. Analysts anticipate that Bioceres Crop Solutions will post -0.16 earnings per share for the current year.
Institutional Trading of Bioceres Crop Solutions
A number of institutional investors and hedge funds have recently made changes to their positions in the company. PDT Partners LLC boosted its position in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $202,000. Squarepoint Ops LLC acquired a new stake in shares of Bioceres Crop Solutions during the 3rd quarter worth approximately $233,000. State of Wisconsin Investment Board acquired a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth approximately $247,000. Finally, Tudor Investment Corp ET AL boosted its position in shares of Bioceres Crop Solutions by 119.4% during the 3rd quarter. Tudor Investment Corp ET AL now owns 220,500 shares of the company’s stock worth $311,000 after acquiring an additional 120,000 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand
- Optical Cable Corporation: Strong Earnings, But Hurdles Remain
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
